Literature DB >> 6238408

Cyclophilin: a specific cytosolic binding protein for cyclosporin A.

R E Handschumacher, M W Harding, J Rice, R J Drugge, D W Speicher.   

Abstract

Cyclophilin, a specific cytosolic binding protein responsible for the concentration of the immunosuppressant cyclosporin A by lymphoid cells, was purified to homogeneity from bovine thymocytes. Cation-exchange high-performance liquid chromatography resolved a major and minor cyclophilin species that bind cyclosporin A with a dissociation constant of about 2 X 10(-7) moles per liter and specific activities of 77 and 67 micrograms per milligram of protein, respectively. Both cyclophilin species have an apparent molecular weight of 15,000, an isoelectric point of 9.6, and nearly identical amino acid compositions. A portion of the NH2-terminal amino acid sequence of the major species was determined. The cyclosporin A-binding activity of cyclophilin is sulfhydryl dependent, unstable at 56 degrees C and at pH 4 or 9.5, and sensitive to trypsin but not to chymotrypsin digestion. Cyclophilin specifically binds a series of cyclosporin analogs in proportion to their activity in a mixed lymphocyte reaction. Isolation of cyclophilin from the cytosol of thymocytes suggests that the immunosuppressive activity of cyclosporin A is mediated by an intracellular mechanism, not by a membrane-associated mechanism.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6238408     DOI: 10.1126/science.6238408

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  416 in total

1.  Metal-dependent nucleotide binding to the Escherichia coli rotamase SlyD.

Authors:  T Mitterauer; C Nanoff; H Ahorn; M Freissmuth; M Hohenegger
Journal:  Biochem J       Date:  1999-08-15       Impact factor: 3.857

2.  Structural consequences of cyclophilin A binding on maturational refolding in human immunodeficiency virus type 1 capsid protein.

Authors:  L Dietrich; L S Ehrlich; T J LaGrassa; D Ebbets-Reed; C Carter
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

Review 3.  Pharmacodynamic monitoring of cyclosporin.

Authors:  W M Awni
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

4.  Introducing immunophilins. From organ transplantation to plant biology.

Authors:  Patrick Romano; Zengyong He; Sheng Luan
Journal:  Plant Physiol       Date:  2004-04       Impact factor: 8.340

5.  The Arabidopsis cyclophilin gene family.

Authors:  Patrick G N Romano; Peter Horton; Julie E Gray
Journal:  Plant Physiol       Date:  2004-03-29       Impact factor: 8.340

Review 6.  Optimisation of immunosuppressive therapy using pharmacokinetic principles.

Authors:  J Grevel
Journal:  Clin Pharmacokinet       Date:  1992-11       Impact factor: 6.447

7.  Analysis of human cell heterokaryons demonstrates that target cell restriction of cyclosporine-resistant human immunodeficiency virus type 1 mutants is genetically dominant.

Authors:  Chisu Song; Christopher Aiken
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

8.  Detailed characterization of a cyclophilin from the human malaria parasite Plasmodium falciparum.

Authors:  M Berriman; A H Fairlamb
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

9.  Effects of the immunosuppressants cyclosporin A and FK 506 on exocytosis in the rat exocrine pancreas in vitro.

Authors:  I H Waschulewski; D V Hall; H F Kern; J M Edwardson
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

10.  The immunosuppressant FK506 inhibits amino acid import in Saccharomyces cerevisiae.

Authors:  J Heitman; A Koller; J Kunz; R Henriquez; A Schmidt; N R Movva; M N Hall
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.